Trial Details

RECRUITING
Basic Information
Clinical ID c867
Identifier NCT05912387
Trial Title Statin Therapy in Primary Sclerosing Cholangitis (PSC): a Multi-omics Study
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Primary Sclerosing Cholangitis|Inflammatory Bowel Diseases
Interventions DRUG: Rosuvastatin
Participant Information
Sponsor Stanford University
City Stanford
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase EARLY_PHASE1
Time Information
Start Date 2023-05-31
Primary Completion Date 2027-05-31
Completion Date 2027-12-31